Investigation of Oxidative Stress in Appendectomy - Open Versus Laparoscopic in Childhood and Adolescence

NCT ID: NCT03723642

Last Updated: 2020-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-02

Study Completion Date

2020-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the planned prospective randomized study, oxidative stress will be investigated by analyzing volatile organic compounds in the exhaled air in children. Children who have undergone open versus laparoscopic surgery for appendicitis will be compared. A better understanding of the effects of the surgical technique could be a prerequisite for an optimized surgical setting. It could also lead to recommendations for pre- or perioperatively antioxidative agents.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim of the study: In the planned prospective randomized study, oxidative stress will be investigated by analyzing VOCs (volatile organic compounds) in the exhaled breath in children undergoing open or laparoscopic surgery for appendicitis at the Department of Pediatric and Adolescent Surgery of the Medical University of Graz. A resulting better understanding of the effects of the surgical technique can a) be a pre-condition for an optimized surgical setting and b) possibly lead to recommendations of pre- or perioperatively antioxidatively active substances and c) be a base for future surgical procedures.

Study design: This is a prospective randomized pilot study in children and adolescents undergoing surgery due to acute appendicitis. Patients with complicated appendicitis and those with an intraoperatively caused disorder will be excluded. The operation within the context of this study is exclusively conducted by specialists of the Department of Pediatric and Adolescent Surgery of the Medical University of Graz, who perform both - open and laparoscopic surgical techniques. 40 patients aged 6-18 years suffering from acute appendicitis are to be included. These are divided into 2 groups. Group 1 (n = 20) with laparoscopic and group 2 (n = 20) with open appendectomy.

Recruitment and compensation of study participants: Parents/patients are made aware of the study by means of an information sheet and are provided with a declaration of consent if interested. Participants do not receive any compensation for participating in the study.

Sampling of exhaled VOCs (volatile organic compounds) using NTME (needle trap microextraction) for measurement OS (oxidative stress): Number of samples: 2 samples each from exhaled breath at the times defined below (in total n = 12). The time of sampling: t1 before anaesthetic introduction (n = 2); t2 after anesthetic introduction (n = 2); t3 15 minutes after cut (n = 2); t4 30 minutes after cut (n = 2); t5 45 minutes after cut (n = 2); t6 after seam (n = 2).

Analysis of exhaled VOCs for measurement OS: The exhaled breath samples taken are placed in an injector of a gas chromatograph into the inert carrier gas stream (He). The substances are assigned according to their retention time in the chromatogram and its mass spectrum. Unknown connections in the mass spectrum of exhaled breath is used as a basis for comparison with a reference database.

Sampling of blood markers for measurement OS: a) sampling times for WBCs, CRP: t1 = 1 sample preoperatively (before anaesthetic introduction) and t2 = 1 sample after 24 h. b) sampling times for malondialdehyde: t1 = 1 sample before anaesthetic introduction and t2 = 1 sample after suture.

Histopathological grading: The explanted vermiform appendix becomes the histopathological Refurbishment at the Institute of Pathology of the Medical University of Graz. There the classification is made according to the histopathological findings in 4 degrees of severity (acute focal appendicitis, acute suppurative appendicitis, acut gangrenous appendicitis, perforated appendicitis).

Sampling WBCs, CRP: These are carried out within the scope of routine diagnostics due to the clinical presentation of the AA (acute appendicitis).

Sampling VOCs: 2 breath samples are taken from each patient during expiration, taken from it. To collect the samples, the investigators use an automatic Sampling device connected directly to a capnometer. This system works with microextraction (NTME) and enables a automatic sampling of the alveolar air, i.e. in the plateau of the CO2 curve. The samples are sent to the Intitute of Rostock Medical Breath Analysis and Technologies (RoMBAT) as cooperation partner. This partner was selected because it already has extensive experience with the methodology and studies on oxidative stress during operations.

Malondialdehyde (MDA) sampling: Malondialdehyde is analysed at the Clinical Institute for Medical and Chemical Laboratory Diagnostics at the Medical University of Graz means of ultra-modern GC-MS method. For this purpose, the patient is assigned to the two Measuring times 2 x 400 μl EDTA plasma taken. The second sample serves only as a safety measure if repeat measurements are necessary. The samples obtained must be deep-frozen at -80 °C within 2 hours. . Subsequently (at the latest on the following day) the samples must be analyzed to the Institute.

Planned evaluation: The statistical investigations are carried out with SPSS 23.0®. Graphical representation of the data is performed with GraphPad Prism 7®. To investigate whether the main target variables (VOCs) differ in the course between the two groups, linear models are used for repeated measurements with group (open versus laparoscopic appendectomy) as intermediate subject factor and time of measurement (t1 to t6) as internal subject factor. In the case of deviations from the normal distribution, transformations are taken into consideration. The secondary targets, i.e. the changes in the serum markers on theTimes t1 and t6, are compared between the 2 groups (open versus laparoscopic appendectomy) by Mann-Whitney U-test (data not normally distributed) or independent T-test (with normal distribution). In order to establish relationships between the VOCs and the serum markers for oxidative stress at times t1 and t6 a correlation analysis is performed (depending on the data, Pearson or Spearman Rho). All statistical tests are carried out on two sides and all p-values are interpreted purely exploratively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Appendicitis Acute

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

40 patients aged 6-18 years suffering from acute appendicitis are to be included. These are divided into 2 groups. Group 1 (n = 20) with laparoscopic and group 2 (n = 20) with open appendectomy.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants
After obtaining written informed consent from patients/legal guardians the patients will be randomized 1:1 to one of the two surgical techniques. Randomization is carried out using the web-based "Randomizer for Clinical Trials" program at the Institute of Medical Informatics, Statistics and Documentation at the Medical University of Graz (www.randomizer.at).

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OAE group

All patients will undergo measurements of oxydative stress (initial serum malondialdehyde level and final serum malondialdehyde level), White blood cell count (initial differential white blood cell count and final differential white blood cell count), c-reactive protein measurements (initial c-reactive protein serum level and final c-reactive protein serum level) as well as volatile organic compound (VOC) sampling (initial VOC, VOC 5min, VOC 15min, VOC 30min, VOC 45min and final VOC).

Group Type ACTIVE_COMPARATOR

Initial serum malondialdehyde level

Intervention Type DIAGNOSTIC_TEST

Blood sample (0.4ml) will be obtained within 5 minutes before induction of general anaesthesia.

Samples will be obtained in both groups (LAE and OAE)

Final serum malondialdehyde level

Intervention Type DIAGNOSTIC_TEST

Blood sample (0.4ml) will be obtained within 5 minutes after wound closure. Samples will be obtained in both groups (LAE and OAE)

Initial differential white blood cell count

Intervention Type DIAGNOSTIC_TEST

Differential blood counts (microscopic) will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).

Final differential white blood cell count

Intervention Type DIAGNOSTIC_TEST

Differential blood counts (microscopic) will be obtained 24h after the first sample (Initial differential blood count).

Samples will be obtained in both groups (LAE and OAE).

Initial c-reactive protein serum level

Intervention Type DIAGNOSTIC_TEST

C-reactive protein levels will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).

Final c-reactive protein serum level

Intervention Type DIAGNOSTIC_TEST

C-reactive protein levels will be obtained 24h after the first sample (initial c-reactive protein level).

Samples will be obtained in both groups (LAE and OAE).

Initial VOC

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) within 10 minutes before induction of general anesthesia

VOC 5min

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within5 minutes) within 5 minutes after endotracheal intubation before skin incision.

VOC 15min

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) 15 minutes after skin incision.

VOC 30min

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) 30 minutes after skin incision.

VOC 45min

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) 45 minutes after skin incision.

Final VOC

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) within 5 minutes after skin closure.

LAE group

All patients will undergo measurements of oxydative stress (initial serum malondialdehyde level and final serum malondialdehyde level), White blood cell count (initial differential white blood cell count and final differential white blood cell count), c-reactive protein measurements (initial c-reactive protein serum level and final c-reactive protein serum level) as well as volatile organic compound (VOC) sampling (initial VOC, VOC 5min, VOC 15min, VOC 30min, VOC 45min and final VOC).

Group Type ACTIVE_COMPARATOR

Initial serum malondialdehyde level

Intervention Type DIAGNOSTIC_TEST

Blood sample (0.4ml) will be obtained within 5 minutes before induction of general anaesthesia.

Samples will be obtained in both groups (LAE and OAE)

Final serum malondialdehyde level

Intervention Type DIAGNOSTIC_TEST

Blood sample (0.4ml) will be obtained within 5 minutes after wound closure. Samples will be obtained in both groups (LAE and OAE)

Initial differential white blood cell count

Intervention Type DIAGNOSTIC_TEST

Differential blood counts (microscopic) will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).

Final differential white blood cell count

Intervention Type DIAGNOSTIC_TEST

Differential blood counts (microscopic) will be obtained 24h after the first sample (Initial differential blood count).

Samples will be obtained in both groups (LAE and OAE).

Initial c-reactive protein serum level

Intervention Type DIAGNOSTIC_TEST

C-reactive protein levels will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).

Final c-reactive protein serum level

Intervention Type DIAGNOSTIC_TEST

C-reactive protein levels will be obtained 24h after the first sample (initial c-reactive protein level).

Samples will be obtained in both groups (LAE and OAE).

Initial VOC

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) within 10 minutes before induction of general anesthesia

VOC 5min

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within5 minutes) within 5 minutes after endotracheal intubation before skin incision.

VOC 15min

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) 15 minutes after skin incision.

VOC 30min

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) 30 minutes after skin incision.

VOC 45min

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) 45 minutes after skin incision.

Final VOC

Intervention Type DIAGNOSTIC_TEST

Volatile organic compound sampling (2 samples within 5 minutes) within 5 minutes after skin closure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Initial serum malondialdehyde level

Blood sample (0.4ml) will be obtained within 5 minutes before induction of general anaesthesia.

Samples will be obtained in both groups (LAE and OAE)

Intervention Type DIAGNOSTIC_TEST

Final serum malondialdehyde level

Blood sample (0.4ml) will be obtained within 5 minutes after wound closure. Samples will be obtained in both groups (LAE and OAE)

Intervention Type DIAGNOSTIC_TEST

Initial differential white blood cell count

Differential blood counts (microscopic) will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).

Intervention Type DIAGNOSTIC_TEST

Final differential white blood cell count

Differential blood counts (microscopic) will be obtained 24h after the first sample (Initial differential blood count).

Samples will be obtained in both groups (LAE and OAE).

Intervention Type DIAGNOSTIC_TEST

Initial c-reactive protein serum level

C-reactive protein levels will be obtained during pre-operative routine work-up.

Samples will be obtained in both groups (LAE and OAE).

Intervention Type DIAGNOSTIC_TEST

Final c-reactive protein serum level

C-reactive protein levels will be obtained 24h after the first sample (initial c-reactive protein level).

Samples will be obtained in both groups (LAE and OAE).

Intervention Type DIAGNOSTIC_TEST

Initial VOC

Volatile organic compound sampling (2 samples within 5 minutes) within 10 minutes before induction of general anesthesia

Intervention Type DIAGNOSTIC_TEST

VOC 5min

Volatile organic compound sampling (2 samples within5 minutes) within 5 minutes after endotracheal intubation before skin incision.

Intervention Type DIAGNOSTIC_TEST

VOC 15min

Volatile organic compound sampling (2 samples within 5 minutes) 15 minutes after skin incision.

Intervention Type DIAGNOSTIC_TEST

VOC 30min

Volatile organic compound sampling (2 samples within 5 minutes) 30 minutes after skin incision.

Intervention Type DIAGNOSTIC_TEST

VOC 45min

Volatile organic compound sampling (2 samples within 5 minutes) 45 minutes after skin incision.

Intervention Type DIAGNOSTIC_TEST

Final VOC

Volatile organic compound sampling (2 samples within 5 minutes) within 5 minutes after skin closure.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age from 6-18 years
* reliable diagnosis of acute appendicitis
* surgical therapy using open/laparoscopic surgical technique
* given approval

Exclusion Criteria

* Age not between 6 and 18 years
* chronic underlying disease/autoimmune disease
* complicated appendicitis (perforation, consecutive purulent peritonitis, abscess formation)
* infection outside acute appendicitis
* SIRS
* taking medications containing the cytochrome P450 (CYP) system affect including cortisone
* impaired liver function
* unaccepted consent
Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Rostock

OTHER

Sponsor Role collaborator

Graz University of Technology

OTHER

Sponsor Role collaborator

Medical University of Graz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Warncke Gert, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Holger Till, MD

Role: STUDY_DIRECTOR

Department of Pediatric and Adolescent Surgery, Medical University of Graz

Gert Warncke, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Pediatric and Adolescent Medicine, Medical University of Graz

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Paediatric and Adolescent Surgery

Graz, , Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gert Warncke, MD

Role: CONTACT

01143316385 ext. 81153

Christoph Castellani, MD

Role: CONTACT

01143316385 ext. 80217

References

Explore related publications, articles, or registry entries linked to this study.

Stringer MD. Acute appendicitis. J Paediatr Child Health. 2017 Nov;53(11):1071-1076. doi: 10.1111/jpc.13737. Epub 2017 Oct 17.

Reference Type BACKGROUND
PMID: 29044790 (View on PubMed)

Ohmann C, Franke C, Kraemer M, Yang Q. [Status report on epidemiology of acute appendicitis]. Chirurg. 2002 Aug;73(8):769-76. doi: 10.1007/s00104-002-0512-7. German.

Reference Type BACKGROUND
PMID: 12425152 (View on PubMed)

Gorter RR, Eker HH, Gorter-Stam MA, Abis GS, Acharya A, Ankersmit M, Antoniou SA, Arolfo S, Babic B, Boni L, Bruntink M, van Dam DA, Defoort B, Deijen CL, DeLacy FB, Go PM, Harmsen AM, van den Helder RS, Iordache F, Ket JC, Muysoms FE, Ozmen MM, Papoulas M, Rhodes M, Straatman J, Tenhagen M, Turrado V, Vereczkei A, Vilallonga R, Deelder JD, Bonjer J. Diagnosis and management of acute appendicitis. EAES consensus development conference 2015. Surg Endosc. 2016 Nov;30(11):4668-4690. doi: 10.1007/s00464-016-5245-7. Epub 2016 Sep 22.

Reference Type BACKGROUND
PMID: 27660247 (View on PubMed)

Binnebosel M, Otto J, Stumpf M, Mahnken AH, Gassler N, Schumpelick V, Truong S. [Acute appendicitis. Modern diagnostics--surgical ultrasound]. Chirurg. 2009 Jul;80(7):579-87. doi: 10.1007/s00104-009-1684-1. German.

Reference Type BACKGROUND
PMID: 19471900 (View on PubMed)

Kim M, Kim SJ, Cho HJ. International normalized ratio and serum C-reactive protein are feasible markers to predict complicated appendicitis. World J Emerg Surg. 2016 Jun 21;11:31. doi: 10.1186/s13017-016-0081-6. eCollection 2016.

Reference Type BACKGROUND
PMID: 27330547 (View on PubMed)

Svensson JF, Hall NJ, Eaton S, Pierro A, Wester T. A review of conservative treatment of acute appendicitis. Eur J Pediatr Surg. 2012 Jun;22(3):185-94. doi: 10.1055/s-0032-1320014. Epub 2012 Jul 5.

Reference Type BACKGROUND
PMID: 22767171 (View on PubMed)

Blakely ML, Williams R, Dassinger MS, Eubanks JW 3rd, Fischer P, Huang EY, Paton E, Culbreath B, Hester A, Streck C, Hixson SD, Langham MR Jr. Early vs interval appendectomy for children with perforated appendicitis. Arch Surg. 2011 Jun;146(6):660-5. doi: 10.1001/archsurg.2011.6. Epub 2011 Feb 21.

Reference Type BACKGROUND
PMID: 21339413 (View on PubMed)

Whyte C, Levin T, Harris BH. Early decisions in perforated appendicitis in children: lessons from a study of nonoperative management. J Pediatr Surg. 2008 Aug;43(8):1459-63. doi: 10.1016/j.jpedsurg.2007.11.032.

Reference Type BACKGROUND
PMID: 18675635 (View on PubMed)

Li X, Zhang J, Sang L, Zhang W, Chu Z, Li X, Liu Y. Laparoscopic versus conventional appendectomy--a meta-analysis of randomized controlled trials. BMC Gastroenterol. 2010 Nov 3;10:129. doi: 10.1186/1471-230X-10-129.

Reference Type BACKGROUND
PMID: 21047410 (View on PubMed)

Coccolini F, Trana C, Sartelli M, Catena F, Di Saverio S, Manfredi R, Montori G, Ceresoli M, Falcone C, Ansaloni L. Laparoscopic management of intra-abdominal infections: Systematic review of the literature. World J Gastrointest Surg. 2015 Aug 27;7(8):160-9. doi: 10.4240/wjgs.v7.i8.160.

Reference Type BACKGROUND
PMID: 26328036 (View on PubMed)

Ciftci F. Laparoscopic vs mini-incision open appendectomy. World J Gastrointest Surg. 2015 Oct 27;7(10):267-72. doi: 10.4240/wjgs.v7.i10.267.

Reference Type BACKGROUND
PMID: 26525039 (View on PubMed)

Noviello C, Romano M, Martino A, Cobellis G. Transumbilical Laparoscopic-Assisted Appendectomy in the Treatment of Acute Uncomplicated Appendicitis in Children. Gastroenterol Res Pract. 2015;2015:949162. doi: 10.1155/2015/949162. Epub 2015 Sep 29.

Reference Type BACKGROUND
PMID: 26491433 (View on PubMed)

Khan SY, Al-Balushi ZN, Bhatti KM, Ehsan T, Mandhan P. Cost Comparison between Laparoscopic and Open Appendectomies in Children. Sultan Qaboos Univ Med J. 2013 May;13(2):275-9. doi: 10.12816/0003234. Epub 2013 May 9.

Reference Type BACKGROUND
PMID: 23862034 (View on PubMed)

Zelzer S, Oberreither R, Bernecker C, Stelzer I, Truschnig-Wilders M, Fauler G. Measurement of total and free malondialdehyde by gas-chromatography mass spectrometry--comparison with high-performance liquid chromatography methology. Free Radic Res. 2013 Aug;47(8):651-6. doi: 10.3109/10715762.2013.812205. Epub 2013 Jul 2.

Reference Type BACKGROUND
PMID: 23745592 (View on PubMed)

McCrum-Gardner E. Which is the correct statistical test to use? Br J Oral Maxillofac Surg. 2008 Jan;46(1):38-41. doi: 10.1016/j.bjoms.2007.09.002. Epub 2007 Oct 24.

Reference Type BACKGROUND
PMID: 17961892 (View on PubMed)

Kapischke M, Pries A, Caliebe A. Short term and long term results after open vs. laparoscopic appendectomy in childhood and adolescence: a subgroup analysis. BMC Pediatr. 2013 Oct 1;13:154. doi: 10.1186/1471-2431-13-154.

Reference Type RESULT
PMID: 24079822 (View on PubMed)

Jaschinski T, Mosch C, Eikermann M, Neugebauer EA. Laparoscopic versus open appendectomy in patients with suspected appendicitis: a systematic review of meta-analyses of randomised controlled trials. BMC Gastroenterol. 2015 Apr 15;15:48. doi: 10.1186/s12876-015-0277-3.

Reference Type RESULT
PMID: 25884671 (View on PubMed)

Minutolo V, Licciardello A, Di Stefano B, Arena M, Arena G, Antonacci V. Outcomes and cost analysis of laparoscopic versus open appendectomy for treatment of acute appendicitis: 4-years experience in a district hospital. BMC Surg. 2014 Mar 19;14:14. doi: 10.1186/1471-2482-14-14.

Reference Type RESULT
PMID: 24646120 (View on PubMed)

Tsai CC, Lee SY, Huang FC. Laparoscopic versus open appendectomy in the management of all stages of acute appendicitis in children: a retrospective study. Pediatr Neonatol. 2012 Oct;53(5):289-94. doi: 10.1016/j.pedneo.2012.07.002. Epub 2012 Sep 1.

Reference Type RESULT
PMID: 23084720 (View on PubMed)

Stipancic I, Zarkovic N, Servis D, Sabolovic S, Tatzber F, Busic Z. Oxidative stress markers after laparoscopic and open cholecystectomy. J Laparoendosc Adv Surg Tech A. 2005 Aug;15(4):347-52. doi: 10.1089/lap.2005.15.347.

Reference Type RESULT
PMID: 16108734 (View on PubMed)

Jakimowicz J, Stultiens G, Smulders F. Laparoscopic insufflation of the abdomen reduces portal venous flow. Surg Endosc. 1998 Feb;12(2):129-32. doi: 10.1007/s004649900612.

Reference Type RESULT
PMID: 9479726 (View on PubMed)

Baysal Z, Togrul T, Aksoy N, Cengiz M, Celik H, Boleken ME, Kaya M, Yavuz G. Evaluation of total oxidative and antioxidative status in pediatric patients undergoing laparoscopic surgery. J Pediatr Surg. 2009 Jul;44(7):1367-70. doi: 10.1016/j.jpedsurg.2008.11.031.

Reference Type RESULT
PMID: 19573663 (View on PubMed)

Aktimur R, Gokakin AK, Deveci K, Atabey M, Topcu O. Oxidative stress markers in laparoscopic vs. open appendectomy for acute appendicitis: A double-blind randomized study. J Minim Access Surg. 2016 Apr-Jun;12(2):143-7. doi: 10.4103/0972-9941.156203.

Reference Type RESULT
PMID: 27073307 (View on PubMed)

Schubert JK, Miekisch W, Geiger K, Noldge-Schomburg GF. Breath analysis in critically ill patients: potential and limitations. Expert Rev Mol Diagn. 2004 Sep;4(5):619-29. doi: 10.1586/14737159.4.5.619.

Reference Type RESULT
PMID: 15347256 (View on PubMed)

Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta. 2004 Sep;347(1-2):25-39. doi: 10.1016/j.cccn.2004.04.023.

Reference Type RESULT
PMID: 15313139 (View on PubMed)

Pabst F, Miekisch W, Fuchs P, Kischkel S, Schubert JK. Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study. J Cardiothorac Surg. 2007 Sep 18;2:37. doi: 10.1186/1749-8090-2-37.

Reference Type RESULT
PMID: 17877828 (View on PubMed)

Trefz P, Rosner L, Hein D, Schubert JK, Miekisch W. Evaluation of needle trap micro-extraction and automatic alveolar sampling for point-of-care breath analysis. Anal Bioanal Chem. 2013 Apr;405(10):3105-15. doi: 10.1007/s00216-013-6781-9. Epub 2013 Feb 7.

Reference Type RESULT
PMID: 23388692 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

30-120 ex 17/18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Laparoscopic Versus Open Appendectomy
NCT02867072 COMPLETED PHASE4
Transvaginal Appendectomy
NCT00806429 COMPLETED NA